ACSL3 and osteosarcoma: Conversely, knocking down ACSL3 in osteosarcoma cells overexpressing BRD4 revealed that the accumulation of arachidonic acid and erastin-ferrop induced by BRD4 can be further attenuated by ACSL3 inhibition (Fig. 5E–J).